IV therapy is a complement to good nutrition, hydration, sleep, and exercise, not a replacement for them
Semaglutide, a GLP-1 receptor agonist, works by enhancing insulin secretion in response to meals and improving cellular insulin sensitivity through multiple metabolic pathways
Comorbidities included smoking, hypertension, and type 2 diabetes mellitus
Its protection extends from the nervous system to the liver, cardiovascular system, and GI tract [11, 34, 35]
PEER REVIEW The peer review history for this article is available at Supporting information ACKNOWLEDGMENTS The authors thank Paul Barlass, PhD, of Axis, a division of Spirit Medical Communications Group Ltd., and Sarah Stowell, a contract writer working on behalf of Axis who provided medical writing assistance under the direction of the authors, funded by Novo Nordisk A/S, Denmark, in accordance with Good Publication Practice 3 (GPP3) guidelines (www.ismpp.org/gpp3)
I couldn't agree more